Lifestyle
Moderna, Merck mRNA Cancer Vaccine Shows Positive Phase 3 Results in Melanoma Trial
Moderna and Merck's personalised mRNA cancer vaccine with Keytruda shows positive Phase 3 results, reducing melanoma recurrence and spread…
Topic
precision oncology
2 stories
Lifestyle
India Launches Single Blood Test to Screen for 10 Common Cancers
India introduces Shield MCD, a single blood test that screens for signals linked to 10 common cancers. The test targets adults aged 45 and…
